DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 0.00 0.00%
S&P 500 2,072.83 5.80 0.28%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

Update: AstraZeneca On A Hot Streak, Announces Positive Data From The Phase 3 Study Of Brodalumab

AstraZeneca/Amgen's Brodalumab Excels in Psoriasis Study - Analyst Blog

Intra-Cellular Commences Phase III Schizophrenia Study - Analyst Blog

CNBC'S Catherine Boyle Doesn't Think A Pfizer/AstraZeneca Deal Will Happen Soon

Today's Market: 7 Stocks Moving On News

Health Care Sector Update for 11/26/2014: ARWR, AMGN, AZN

5 Things Pfizer, Inc.'s Management Wants You to Know

Pfizer's third-quarter earnings report looked rather tame unless you dug into its quarterly conference call. Here are the five key things Pfizer's management wants you to know about where the company is headed next.

Update: AstraZeneca Wins EC Marketing Authorization For Duaklir Genuair

Novartis' Psoriasis Drug Cosentyx Backed for EU Approval - Analyst Blog

Stop Worrying About Ebola: This is a Much More Pressing Concern

Ebola may be garnering all of the headlines, but this infectious disease has been a contributing factor to the eighth leading cause of death in the U.S.
See More Articles...